A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes | Zendy

Zaid Kilani | Zendy

Open Access

A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes

Author(s) -

Zaid Kilani

Publication year - 2003

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/deg252

Subject(s) - menotropins , medicine , regimen , pregnancy rate , hmg coa reductase , gonadotropin , andrology , endocrinology , embryo transfer , miscarriage , testosterone (patch) , prospective cohort study , pregnancy , follicle stimulating hormone , ovulation induction , ovulation , biology , hormone , luteinizing hormone , biochemistry , reductase , genetics , enzyme

To assess the clinical profile and efficacy in assisted reproductive treatment of a new human-derived highly purified (HP) menotropin, we compared HP hMG and recombinant (r) FSHalpha use in ICSI within a prospective, randomized, controlled study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research